- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Scott Commins on Expanding Awareness of Food Allergy Manifestations to Other Specialists
There are greater awareness efforts taking place to educate other specialists on referring patients who are having suspected allergic reactions to the appropriate allergists, who can do a fuller evaluation, said Scott P. Commins, MD, PhD, associate professor of medicine, at the University of North Carolina.
There are greater awareness efforts taking place to educate other specialists on referring patients who are having suspected allergic reactions to the appropriate allergists, who can do a fuller evaluation, said Scott P. Commins, MD, PhD, associate professor of medicine, at the University of North Carolina.
Transcript
What efforts are taking place to educate other specialties, such as pediatricians, internists, emergency providers, and others, about best practices in food allergy prevention and treatment?
I think there’s a lot of awareness going on whether it’s through the Food Allergy Research and Education Group or even coming out through the allergy journals, but then equally trying to get awareness to physicians who are on the frontline whether it’s adult food allergy or childhood. Mainly with the idea of “If you suspect this is happening, it’s totally appropriate to refer these folks and don’t even necessarily need to do the evaluation in your office.” I think most allergists are more than pleased to do the full evaluation in their office, where we have the full capability to do skin testing, we’re proficient with the bloodwork, and it saves, often, confusion about this.
I think the other aspect of this is broadening the idea of what we kind of define of food allergy as. So, empowering our gastroenterologists or dermatologists to think about either belly pain or say, hives, respectively, as potential manifestations of food allergy. Go ahead and make that referral and [we’d] be happy to see those patients.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
